HIV-1 – pharmaceutical daily

June 12, 2020 Off

FDA approves ViiV Healthcare’s dolutegravir tablet for children living with HIV

ViiV Healthcare Friday said that the US Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir) tablets for oral suspension, used combined with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in certain young patients.

September 20, 2019 Off

Merck’s Pifeltro and Delstrigo get US FDA approval for use in appropriate virologically suppressed adults living with HIV-1

By BusinessWire

USAFDA has given approvals for Merck’s Pifeltro and Delstrigo for certain HIV-1 patients, based on fFindings from the Phase 3 DRIVE-SHIFT Trial, Merck said on Friday in a press release.

September 26, 2017 Off

Janssen files NDA to U.S. FDA for the first Darunavir-based tablet for HIV-1

By Dino Mustafić

Janssen has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for darunavir several doses, for…